A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 14.28 CNY -4.86% Market Closed
Market Cap: 132B CNY
Have any thoughts about
Aier Eye Hospital Group Co Ltd?
Write Note

Aier Eye Hospital Group Co Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aier Eye Hospital Group Co Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Common Shares Outstanding
ÂĄ9.3B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
10%
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Common Shares Outstanding
ÂĄ616.7m
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Hengkang Medical Group Co Ltd
SZSE:002219
Common Shares Outstanding
ÂĄ3.4B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
8%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Common Shares Outstanding
ÂĄ2.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
2%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Common Shares Outstanding
ÂĄ840m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Common Shares Outstanding
ÂĄ206m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aier Eye Hospital Group Co Ltd
Glance View

Market Cap
133.2B CNY
Industry
Health Care

Aier Eye Hospital Group Co., Ltd., founded in 2001 and headquartered in Changsha, China, has emerged as a leading player in the ophthalmology healthcare sector in Asia. Starting as a single eye clinic, it has grown exponentially to encompass a vast network of over 60 hospitals and numerous outpatient service centers across China and beyond. The company focuses on providing comprehensive eye care services, including cataract surgery, myopia treatment, and other advanced healthcare solutions, leveraging cutting-edge technology and innovative techniques. With a dedicated team of skilled specialists and a commitment to enhancing patient outcomes, Aier aims to address the increasing demand for vision care in a rapidly aging population, underpinned by a robust business model that merges quality healthcare delivery with strategic expansion. As an investor, Aier Eye Hospital presents a compelling opportunity in the burgeoning health sector. With healthcare spending expected to rise in China and globally, Aier's prominence in eye care positions it well to tap into this growing market. The company's commitment to research and development ensures continuous innovation and adaptation to emerging healthcare trends, setting it apart from traditional healthcare providers. Furthermore, Aier's expansion strategy, including potential international outreach, offers a promise of sustained growth. By investing in Aier, one is not just supporting a service provider but joining a forward-thinking healthcare institution that is poised to redefine eye care and generate significant returns.

Intrinsic Value
18.1 CNY
Undervaluation 21%
Intrinsic Value
Price
A

See Also

What is Aier Eye Hospital Group Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
9.3B CNY

Based on the financial report for Sep 30, 2024, Aier Eye Hospital Group Co Ltd's Common Shares Outstanding amounts to 9.3B CNY.

What is Aier Eye Hospital Group Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
10%

Over the last year, the Common Shares Outstanding growth was 1%. The average annual Common Shares Outstanding growth rates for Aier Eye Hospital Group Co Ltd have been 10% over the past three years , 18% over the past five years , and 10% over the past ten years .

Back to Top